Prevention of mother-to-child transmission

Blog
October 26, 2018
Prevention of mother-to-child transmission of HIV (PMTCT) programs have been incredibly successful across southern Africa. However, presentations at the second day of the Southern African HIV Clinicians Society Conference highlighted important gaps in pediatric testing and treatment.
Resource
October 26, 2018
PrEP could complement established HIV prevention strategies for pregnant and breastfeeding women as part of a comprehensive package to reduce HIV infections among women and transmission from mothers to infants in settings with high HIV incidence.
Resource
October 18, 2018

The Southern African HIV Clinicians Society’s biannual conference focuses on clinical content for HIV and TB health care workers in the region.

Blog
October 12, 2018
Despite the fact that people under the age of 18 make up about 25% of the global population, research among adolescents has been a neglected area. We know that it is important to conduct research among pediatric and adolescent populations, but to date the focus has remained on adults. Just how significant the risks are of not including adolescents in clinical trials emerged as a key theme at the 2nd International Workshop on HIV Adolescence, as well as the logistical, ethical, legal, justice, and human rights considerations that need to be taken into account when designing and implementing research involving adolescents.
Resource
September 4, 2018

The Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative was a public-private partnership that expanded pediatric HIV services in nine sub-Saharan African countries from 2014-2016, providing treatment to more than 560,000 children living with HIV.

Resource
August 23, 2018

Background: The recent scale-up of prevention of mother-to-child transmission of HIV (PMTCT) services has rapidly accelerated antiretroviral therapy (ART) uptake among pregnant and postpartum women in sub-Saharan Africa.

Resource
July 31, 2018

Background
Understanding the absolute and relative risk of human immunodeficiency virus type 1 (HIV) acquisition during pregnancy and the postpartum period can inform HIV prevention strategies for women.

Blog
July 25, 2018
Bright and early Wednesday morning, nine speakers and more than 70 participants from international development organizations, donor agencies, and academia gathered at AIDS 2018 to discuss best practices and lessons learned from The Accelerating Children’s HIV/AIDS Treatment (ACT), reflecting how we can sustain and continue to accelerate progress in reaching children and adolescents living with HIV. Participants asked thoughtful questions and engaged in lively discussion with the panel of speakers, including reflection on challenges with case identification and the need for countries to strategically position point of care diagnostics.
Resource
July 25, 2018

Baylor-Malawi, with USAID funding, has developed a special JAIDS supplement featuring 11 articles which highlight lessons and best practices from the Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative, a public-private partnership that expanded pediatric HIV services in nine sub-Saharan

Resource
July 23, 2018

Since WHO published the 2016 ARV guidelines, several studies have evaluated the safety and efficacy of dolutegravir (DTG) during pregnancy and the periconcep